AI assistant could cut doctor review time for heart disease diagnoses

NCT ID NCT07414966

Not yet recruiting Diagnosis Sponsor: China National Center for Cardiovascular Diseases Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests a tool called SCOUT that helps doctors check AI-generated diagnoses for coronary heart disease. Seven cardiologists will review cases either with SCOUT's assistance or through standard manual review. The goal is to see if SCOUT can reduce the time doctors spend per case while keeping diagnostic accuracy high.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SCOUT framework (AI oversight tool) and DeepSeek-V3.1 large language model
What this could lead to: If successful, this could point toward a safer, faster way for doctors to use AI in diagnosing heart disease, reducing their workload without missing critical cases.
What could go wrong: This is a very small, early-stage trial with only 7 doctors, so results may not apply broadly. The AI may still make errors, and the tool might not save much time in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE (CHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY HEART DISEASE (CHD)

More trials for these conditions

Other studies related to the condition(s) this trial covers.